Gan & Lee Pharmaceuticals Co., Ltd. Class ASSE: 603087

Announcement on Completion of Administration of the First Subject in Phase I Clinical Trial of GLR2037 Tablets

· Issued by Gan & Lee Pharmaceuticals Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Completion of Administration of the First Subject in Phase I Clinical Trial of GLR2037 Tablets

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment